| 注册
首页|期刊导航|福建师范大学学报(自然科学版)|抗肿瘤纳米药物的器官选择性靶向机制与研究进展

抗肿瘤纳米药物的器官选择性靶向机制与研究进展

雷泽宇 林晨煜 彭海豹

福建师范大学学报(自然科学版)2026,Vol.42Issue(5):78-88,11.
✕
福建师范大学学报(自然科学版)2026,Vol.42Issue(5):78-88,11.DOI:10.12046/j.issn.1000-5277.2026050009

抗肿瘤纳米药物的器官选择性靶向机制与研究进展

Organ-selective targeting mechanisms and research advances in antitumor nanomedicines

雷泽宇 1林晨煜 2彭海豹3

作者信息

  • 1. 复旦大学脑科学转化研究院,上海 200032||复旦大学基础医学院,上海 200032
  • 2. 复旦大学脑科学转化研究院,上海 200032||复旦大学附属中山医院,上海 200032
  • 3. 复旦大学脑科学转化研究院,上海 200032
  • 折叠

摘要

Abstract

Malignant tumors remain a major threat to human health,and conventional therapies are often associated with significant toxic side effects due to their lack of selectivity.Nanocarriers provide a promising strategy for precise drug delivery;however,low in vivo delivery efficiency and nonspecific accumulation remain major obstacles to their clinical translation.In recent years,organ-selective targeting has emerged as an important approach to overcoming these bottlenecks,as it can elevate local drug concentrations at lesion sites while reducing systemic toxicity.This review system-atically summarizes the key physiological barriers encountered during in vivo nanomedicine delivery and the mechanisms for overcoming these barriers,with a focus on the structural features of different organs and the corresponding targeting strategies.Representative research advances in organ-selec-tive antitumor nanomedicines in recent years are also outlined.On this basis,future development directions,including the synergistic overcoming of multiple barriers and artificial intelligence-assisted design,are discussed,aiming to provide a reference for research and clinical translation in this field.

关键词

抗肿瘤纳米药物/器官选择性靶向/递送屏障/靶向策略/纳米药物设计

Key words

antitumor nanomedicines/organ-selective targeting/delivery barriers/targeting strategies/nanomedicine design

分类

医药卫生

引用本文复制引用

雷泽宇,林晨煜,彭海豹..抗肿瘤纳米药物的器官选择性靶向机制与研究进展[J].福建师范大学学报(自然科学版),2026,42(5):78-88,11.

基金项目

国家自然科学基金项目(62475047) (62475047)

福建师范大学学报(自然科学版)

1000-5277

访问量0
|
下载量0
段落导航相关论文